Zaptec ASA (FRA:6I4) reports a 23% revenue increase and significant order backlog growth, while addressing inventory challenges and market expansion strategies.

Despite not reaching last year's record revenues, PWP showcases robust fundamentals with strategic acquisitions and a strong cash position, setting the stage for future expansion.

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...